PMC:7228307 / 69-290 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"22","span":{"begin":95,"end":100},"obj":"Species"}],"attributes":[{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":177,"end":191},"obj":"Body_part"},{"id":"T3","span":{"begin":192,"end":197},"obj":"Body_part"},{"id":"T4","span":{"begin":193,"end":195},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":52,"end":54},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0020320"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":24,"end":26},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T5","span":{"begin":95,"end":100},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T6","span":{"begin":126,"end":128},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":159,"end":166},"obj":"Chemical"},{"id":"T2","span":{"begin":198,"end":205},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_52214"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":177,"end":191},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T2","span":{"begin":193,"end":195},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"},{"id":"A2","pred":"meddra_id","subj":"T2","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"22","span":{"begin":95,"end":100},"obj":"Species"}],"attributes":[{"id":"A22","pred":"pubann:denotes","subj":"22","obj":"Tax:9606"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T1","span":{"begin":95,"end":100},"obj":"Species"}],"attributes":[{"id":"A1","pred":"ncbi_taxonomy_id","subj":"T1","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T2","span":{"begin":24,"end":51},"obj":"Sentence"},{"id":"T3","span":{"begin":52,"end":71},"obj":"Sentence"},{"id":"T4","span":{"begin":73,"end":81},"obj":"Sentence"},{"id":"T5","span":{"begin":82,"end":90},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T2","span":{"begin":177,"end":191},"obj":"Body_part"},{"id":"T3","span":{"begin":192,"end":197},"obj":"Body_part"},{"id":"T4","span":{"begin":193,"end":195},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}

{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":24,"end":51},"obj":"Sentence"},{"id":"T3","span":{"begin":52,"end":71},"obj":"Sentence"},{"id":"T4","span":{"begin":73,"end":81},"obj":"Sentence"},{"id":"T5","span":{"begin":82,"end":90},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"athway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activat"}